ERBB2 promoter demethylation and immune cell infiltration promote a poor prognosis for cancer patients is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0.292. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Anhui Provincial Department of Education
Grant: KJ2020A0621
Anhui University of Science and Technology
Grant: 202004a07020042
Anhui Provincial Department of Education
Grant: YJ20210556
Anhui Provincial Development and Reform Commission
FWCI
0.31
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals